C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/76 (2006.01) A61K 31/40 (2006.01) A61K 31/445 (2006.01) C07D 207/26 (2006.01) C07D 401/12 (2006.01) C07D 409/14 (2006.01) C07K 5/078 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2384247
The present invention is directed to non-peptidic factor Xa inhibitors which are useful for the treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and neurodegenerative diseases. The factor Xa inhibitors provide compounds having Formula (I) or pharmaceutically acceptable salts thereof; wherein Q is phenyl, benzyl, pyridyl, thienyl, indolyl, quinolinyl, benzothienyl, biphenylyl, or imidazolyl; any of which can include one or more optional substituents independently selected from halo, trifluoromethyl, hydroxy, amino, nitro, cyano, C1-3 alkoxy, C1-3 alkyl, methylenedioxy, carboxamido, acetamido, or amidino; X is methylene, carbonyl, or sulfonyl; Z is methylene, ethylene, or propylene; M is methylene or ethylene; and R1, R2 and R3 are independently hydrogen or C1-3 alkyl.
L'invention concerne des inhibiteurs du facteur Xa non peptidique, utiles au traitement de troubles d'occlusion thrombotiques artériels et veineux, d'inflammations, de cancer et de maladies neurodégénératives. Les inhibiteurs du facteur Xa produisent des composés de la formule (I) ou des sels de ceux-ci pharmaceutiquement acceptables. Q est phényle, benzyle, pyridyle, indolyle, quinolinyle, benzothiényle, biphénylyle ou imidazolyle, qui peuvent indifféremment renfermer au moins un substituant facultatif indépendamment choisi parmi halo, trifluorométhyle, hydroxy, amino, nitro, cyano, C¿1-3? alcoxy, C¿1-3? alkyle, méthylènedioxy, carboxamido, acétamido ou amidino; X représente méthylène, carbonyle ou sulfonyle; Z représente méthylène, éthylène ou propylène; M représente méthylène ou éthylène et R?1¿, R?2¿ et R?3¿ représentent individuellement hydrogène ou C¿1-3? alkyle.
Hall Jonathan P.
Haslow Kristin D.
Marugan Sanchez Juan Jose
Miller Scott C.
3-Dimensional Pharmaceuticals Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Azacycloalkanone serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azacycloalkanone serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azacycloalkanone serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1375335